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and Major Aortopulmonary CollateralsFigure 1 Illustrations of the 4 Anomalous Coronary Artery Patterns
(A) Anomalous origin of the left anterior descending (LAD) originating from the right
coronary artery (RCA). This was the most common anomalous pattern, accounting
for 9 of 17 cases. (B) Anomalous origin of a coronary branch originating from the
RCA and supplying the interventricular septum. There is also an LAD with a normal
origin and course (dual LAD). (C) Anomalous origin of the RCA from the LAD. (D)
Anomalous origin of a branch of the RCA originating from the LAD supplying the
free wall of the right ventricle. There is also a separate RCA with a normal origin
and course.To the Editor: Pulmonary atresia (PA) with ventricular septal defect
(VSD) and major aortopulmonary collaterals (MAPCA) is a
member of the conotruncal defect family. These defects all origi-
nate from abnormal embryogenesis of the conotruncus at 27 to
37 days of fetal life. PA/VSD/MAPCA has many of the charac-
teristic hallmarks of conotruncal defects, including a malalignment
VSD and the most extreme disparity in septation of the con-
otruncus. The common embryogenesis results in many similarities
across a wide range of anatomic malformations.
Anomalous coronary arteries are another hallmark of conotruncal
defects. Tetralogy of Fallot has a 5% prevalence of anomalous
coronaries, whereas truncus arteriosus is approximately 30%. The
clinical implications of anomalous patterns can be profound, as
documented for the left anterior descending coronary originating
from the right coronary in tetralogy of Fallot.
PA/VSD/MAPCA is a relatively uncommon form of congenital
heart defect, and advances in treatment have been shown by our
group and others (1). However, the prevalence of coronary artery
anomalies for PA/VSD/MAPCA has not been documented. The
purpose of the present study was to evaluate the prevalence of
anomalous coronary patterns in PA/VSD/MAPCA.
This study was approved by the Institutional Review Board of
Stanford University. Sixty-four consecutive patients undergoing
single-stage complete repair (2009 through 2012) were included.
The intra-operative coronary artery patterns were documented
based on the surface anatomy.
These intra-operative observations were compared to the pre-
operative cardiac catheterization.
There were 38 female and 26 male subjects. Median age at
surgery was 10.3 months (range: 5 days to 12.5 years) and median
weight was 6.3 kg (range: 2.3 to 32 kg).
Forty-seven of the 64 patients (73%) had a normal coronary
artery pattern identiﬁed intra-operatively, whereas 17 patients
(27%) had an anomalous coronary artery pattern. There were 4
anomalous coronary patterns observed. The most frequently
encountered anomalous course was a left anterior descending
(LAD) originating from the right coronary (Fig. 1A), identiﬁed in
15% of patients. The other 3 anomalous patterns (Figs. 1B to 1D)
were observed collectively in 11% of patients. One patient had an
anomalous origin of the right coronary artery from the noncoronary
sinus of Valsalva.
Cardiac catheterization corroborated the coronary artery pattern
found intra-operatively in 58 of 64 (91%) cases. The 6 cases in
which the cardiac catheterization did not correlate were all false
negatives. Two of the false negatives had a dual LAD, 2 had a
coronary branch to the right ventricular free wall from the LAD,
and 1 had the entire right coronary originating from the LAD. The
ﬁnal false negative was the right coronary from the noncoronary
sinus.In addition to the anomalous coronary patterns, 3 patients had
a pulmonary artery from a coronary and 2 patients had a MAPCA
from a coronary artery.
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1128This manuscript describes the coronary artery patterns in 64
consecutive patients undergoing repair of PA/VSD/MAPCA.
Twenty-seven percent of the patients had an anomalous origin and
course of their coronary arteries. The most frequently observed
anomalous course was a LAD originating from the right coronary
and accounted for 15% of all anomalous patterns.
This prevalence of coronary arterial anomalies in PA/VSD/
MAPCA is at the high end of the spectrum compared with other
forms of conotruncal defects.
There was a 91% correlation between the coronary artery
patterns identiﬁed at surgery and the ﬁndings described by cardiac
catheterization. The 9% of patients who were not correctly iden-
tiﬁed at catheterization were all false negatives. The speciﬁcity of
cardiac catheterization was 100% and the sensitivity was 65%. Five
of the 6 false negatives had 2 separate coronary ostia, emphasizing
the need to exclude all 4 anomalous coronary patterns.
Recognition of coronary artery anomalies is important in PA/VSD/
MAPCA due to the need for placement of a conduit from the right
ventricle to the reconstructed pulmonary arteries. The surface anatomy
of the coronary system is discernible at the time of the ﬁrst surgical
procedure, and this is why this is a requirement for inclusion in this
study. The ability to see the coronary arterial pattern at ﬁrst surgery
allows safe placement of the proximal end of the conduit regardless of
the presence or absence of anomalous coronaries. The surface anatomy
is obscured in subsequent re-operations, and during these subsequent
conduit changes, injury to coronary arteries can occur. In view of the
relatively high prevalence of anomalous coronaries in PA/VSD/
MAPCA, it is imperative to identify the coronary artery pattern prior to
contemplating re-operations for conduit replacement.
In summary, this study has documented a 27% incidence of
anomalous coronary arteries in patients with PA/VSD/MAPCA.
This information is clinically important to avoid coronary injuries
during conduit re-operations.
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1397–402.Letters to the EditorAll Vasodilators Are Not EqualWe read with interest the paper published by Naya et al. (1), in
which they suggest that global coronary ﬂow reserve (CFR), and
not coronary artery calcium, as assessed by positron emission
tomographic (PET) myocardial perfusion imaging (MPI), provides
signiﬁcant incremental improved risk stratiﬁcation over clinical risk
scores for prediction of major adverse cardiac events (1). However,
we feel the results should be interpreted with caution for the
following reasons.
This large study (n¼ 901) permitted the use of 4 different types of
vasodilators to assess CFR: dipyridamole (52% of patients), rega-
denoson (38%), adenosine (5%), and dobutamine (5%). The inves-
tigators assumed that each pharmacological agent would produce an
equivalent vasodilator effect, and therefore, allow collective
comparison of CFR with outcome variables. However, this
assumption is unproven and unlikely to be correct given their
different modes of action. As such, this could have a profound effect
on the study endpoints. Previous comparative studies that have
involved small numbers of patients have demonstrated that these
pharmacological agents produce signiﬁcantly different magnitudes
of hemodynamic and vasodilator effects. Importantly, where
differences have not been shown, this does not mean they do not
exist, and may be due to the limited numbers of patients studied.
Vasu et al. (2) used stress cardiac magnetic resonance imaging
(MRI) in 40 patients and showed that regadenoson had a 20%
signiﬁcantly greater vasodilator effect than dipyridamole on myo-
cardial blood ﬂow reserve. In 20 healthy volunteers, dobutamine-
atropine infusion caused a 40% greater increase in peak myocardial
blood ﬂow as measured by PETMPI in comparison to dipyridamole
(3). In a separate study, adenosine was shown to produce a signiﬁ-
cantly greater decrease in mean arterial blood pressure than dipyr-
idamole, and althoughmyocardial bloodﬂow reservewas numerically
greater with adenosine, it did not reach statistical signiﬁcance (4).
This study involved just 15 patients.
The investigators also attempted to exclude patients with
obstructive coronary artery disease from the study on the basis of
an abnormal PET MPI. As a result, almost a quarter of the 1,240
patients screened were rejected. Unfortunately, an inherent
methodological problem, known as incorporation bias, arises
when the same technique is used both as a gatekeeper for
“abnormal patients” and also acts as the diagnostic test. This
problem is further compounded when no criteria are given as to
how an “abnormal PET MPI” was deﬁned. For example, readers
would wish to know whether all 1,240 PET MPI scans had ﬂows
quantitatively assessed. In which case, what cutoff values for
blood ﬂow were used to deﬁne obstructive disease? Clearly,
inadvertent exclusion of scans presumed to be abnormal due to
obstructive coronary artery disease, but which were due to
microvascular dysfunction, could signiﬁcantly affect the outcome
of the study.
We look forward to the authors’ reply.
